- Home
- WOW vs NGNE Comparison
WOW vs NGNE Comparison
Compare WOW & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- NGNE
- Stock Information
- Founded
- WOW 2001
- NGNE 2003
- Country
- WOW United States
- NGNE United States
- Employees
- WOW N/A
- NGNE N/A
- Industry
- WOW Cable & Other Pay Television Services
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- NGNE Health Care
- Exchange
- WOW Nasdaq
- NGNE Nasdaq
- Market Cap
- WOW 440.8M
- NGNE 426.6M
- IPO Year
- WOW 2017
- NGNE N/A
- Fundamental
- Price
- WOW $5.14
- NGNE $31.06
- Analyst Decision
- WOW Hold
- NGNE Strong Buy
- Analyst Count
- WOW 2
- NGNE 8
- Target Price
- WOW $5.20
- NGNE $44.75
- AVG Volume (30 Days)
- WOW 389.1K
- NGNE 256.6K
- Earning Date
- WOW 11-11-2025
- NGNE 11-18-2025
- Dividend Yield
- WOW N/A
- NGNE N/A
- EPS Growth
- WOW N/A
- NGNE N/A
- EPS
- WOW N/A
- NGNE N/A
- Revenue
- WOW $604,800,000.00
- NGNE N/A
- Revenue This Year
- WOW N/A
- NGNE N/A
- Revenue Next Year
- WOW N/A
- NGNE N/A
- P/E Ratio
- WOW N/A
- NGNE N/A
- Revenue Growth
- WOW N/A
- NGNE N/A
- 52 Week Low
- WOW $3.06
- NGNE $6.88
- 52 Week High
- WOW $5.78
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- WOW 55.30
- NGNE 55.88
- Support Level
- WOW $5.12
- NGNE $30.52
- Resistance Level
- WOW $5.17
- NGNE $35.47
- Average True Range (ATR)
- WOW 0.02
- NGNE 3.30
- MACD
- WOW -0.01
- NGNE -0.24
- Stochastic Oscillator
- WOW 30.00
- NGNE 37.85
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.